key: cord-0832306-i0v7dstx authors: Robles-Remacho, Agustín; Luque-González, M. Angélica; González-Casín, Roberto A.; Cano-Cortés, M. Victoria; Lopez-Delgado, F.Javier; Guardia-Monteagudo, Juan J.; Antonio Fara, Mario; Sánchez-Martín, Rosario M.; Díaz-Mochón, Juan José title: Development of a nanotechnology-based approach for capturing and detecting nucleic acids by using flow cytometry date: 2021-01-09 journal: Talanta DOI: 10.1016/j.talanta.2021.122092 sha: 43b5eca189ed62887c827ccf2234842e75e92e19 doc_id: 832306 cord_uid: i0v7dstx Nucleic acid-based molecular diagnosis has gained special importance for the detection and early diagnosis of genetic diseases as well as for the control of infectious disease outbreaks. The development of systems that allow for the detection and analysis of nucleic acids in a low-cost and easy-to-use way is of great importance. In this context, we present a combination of a nanotechnology-based approach with the already validated dynamic chemical labeling (DCL) technology, capable of reading nucleic acids with single-base resolution. This system allows for the detection of biotinylated molecular products followed by simple detection using a standard flow cytometer, a widely used platform in clinical and molecular laboratories, and therefore, is easy to implement. This proof-of-concept assay has been developed to detect mutations in KRAS codon 12, as these mutations are highly important in cancer development and cancer treatments. Early, rapid, and effective nucleic acid analysis is currently in demand for the diagnosis of genetically-based and infectious diseases [1, 2] . It is a key tool for early diagnosis, accurate prognosis, and control of disease outbreaks. It is noteworthy that it can also be used for treatment management in personalised medicine. The gold standard for nucleic acid analysis is quantitative polymerase chain reaction (qPCR) and reverse-transcription quantitative PCR (RT-qPCR), when RNA is analysed, because of its high specificity, sensitivity, and reproducibility. However, qPCR is not exempt from issues. For instance, during the COVID-19 pandemic, the use, almost exclusively, of PCR-based assays for identifying SARS-CoV-2 created huge problems in terms of material accessibility and the need to work with isolated RNA molecules [3, 4] . Thus, developing new methods to rapidly detect and genotype nucleic acids with high specificity is important in the molecular testing field. In this context, technologies that can offer advantages over PCR assays, such as working directly with complex matrix samples while maintaining the high specificity of PCR, are of great interest. Herein, we have developed a novel strategy for nucleic acid reading with single-base resolution based on the combination of bifunctional polystyrene nanoparticles (PS-NPs) for the capture and analysis of biotinylated products generated by dynamic chemical labelling (DCL) ( Figure 1A ). DCL is an already validated and versatile chemical-based approach that harnesses the Watson and Crick base-pairing rules for templating the dynamic incorporation of an aldehydemodified nucleobase (SMART-Nucleobase) into the abasic position of an abasic peptide nucleic acid (PNA) probe, also known as a DGL probe (see chemical structure in Supporting Information 1) [5, 6] . These two key reagents, the DGL probe and the SMART-Nucleobase, can be modified and tagged, enabling the detection of DCL products by fluorescence, mass spectroscopy, colourimetry, and chemiluminescence. The DCL reaction comprises several steps: in the first step, the DGL probe hybridises with a complementary target nucleic acid forming a DGL:DNA heteroduplex ( Figure 1B, step I) . This hybridisation occurs so that the nucleotide under interrogation at the target nucleic acid strand lays opposite to the abasic position of the DGL probe, creating a so-called chemical pocket. In this chemical pocket, a reversible reaction between the aldehyde group of the SMART-Nucleobase and the secondary amine found in the abasic position results in different and unstable iminium intermediate species (Figure 1B stable, allowing the next step, the irreversible reductive amination, which covalently links the SMART-Nucleobase into that position ( Figure 1B, step III) . Herein, the DCL product formed will be captured by the PS-NPs for analysis by Fluorescence-Activated Cell Sorting (FACS). One of the advantages of DCL, compared to standard molecular assays, is its ability to detect nucleic acids directly from body fluids without the need to isolate them. Our group has developed several DCL-based approaches that have been successfully applied to different nucleic acid targets using different biological matrices. For instance, the method was used to genotype single nucleotide polymorphisms related to cystic fibrosis [7] , to quantify the circulating miRNAs found in the serum of patients [8] [9] [10] [11] [12] [13] , and to identify parasitic species by identifying single nucleotide differences within highly homologous regions [14, 15] . Most of the latest applications of DCL use DGL probes conjugated to solid supports such as nylon membranes and magnetic beads, so that standard reading platforms that are available in molecular biology laboratories could be used [16] . In this work, we aimed to use nanoparticles but as solid supports to capture and detect the formed heteroduplexes rather than as solid supports to conjugate DGL probes. Therefore, the hybridisation processes can take place in solution, which means that they are thermodynamically favourable when compared to solid-phase processes [17] [18] [19] . To achieve this, we used PS-NPs due to their robustness and stability in the biological environment, and their compatibility with standard multistep chemistries, allowing different orthogonal conjugation strategies [20] [21] [22] [23] [24] [25] [26] . The novel PS-NPs used in this work are bifunctionalised containing both a streptavidin as the high-affinity partner of biotin, and a fluorophore (5(6)- We performed this proof-of-concept using KRAS codon 12 p.G12C (c.34G > T) mutation, the most frequent mutation in lung adenocarcinoma [27] , as the model. The appearance of point mutations in the KRAS gene triggers cancer development, and represents around 20-30% of all mutations found in human tumours, predominantly adenocarcinomas (pancreatic, colorectal, lung, ovarian, cervical, and biliary tract adenocarcinomas) [2, 28, 29] . About 99% of mutations in KRAS are point mutations in codons 12, 13, and 61 of exon 2. Additionally, the proof-ofconcept has been validated to detect miR-122 sequence, a liver-specific miRNA used as a biomarker of liver damage [12, 30] , and is also associated with hepatocellular carcinoma development [8, 12, 13] All chemicals and solvents were obtained from Sigma Aldrich. SCD buffer was prepared from 2× saline sodium citrate (SSC) and 0.1% sodium dodecyl sulphate (SDS) with the pH adjusted to 6.0 using HCl. Fmoc-PEG 3 -COOH and Fmoc-Lys(Dde)-OH were synthesised as previously in the APC channel, and data were analysed using one-way ANOVA. PS-NPs (1) (360 nm in size) were synthesised following a dispersion polymerisation process as previously reported [31] . Fmoc-Dde-NPs (8) were prepared according to previously described protocols [23] . Briefly, coupling reactions were carried out in dimethylformamide (DMF) using the Fmoc-NH-protected monomer (50 equiv) with oxyma (50 equiv) and N,N'diisopropylcarbodiimide (DIC) (50 equiv) as coupling agents (see Synthetic single-stranded DNA (ssDNA) oligomers mimicking codon 12 of KRAS wild-type sequence and KRAS containing G12C mutation sequence (ssDNA-KRAS-wt-Cy5, ssDNA-KRAS-wt-biotin, and ssDNA-KRAS-G12C-Cy5) were purchased from Sigma Aldrich (see Table 1 for sequences). All sequences were obtained using BLAST analysis [32] . SMART-Cytosine-PEG 12 Table 1) . Synthetic single-stranded DNA and probes used for the validation of this system using miR-122 sequence as a target are detailed in Supporting Information 4. Bifunctional Strep-FAM-NPs (13), designed to capture biotinylated molecular products, were efficiencies were monitored using the Kaiser colorimetric test [33] . To achieve efficient covalent functionalization of both cargoes to PS-NPs in a controlled manner, an orthogonal strategy, based on the full orthogonality between Dde and Fmoc protecting groups was carried out to achieve Fmoc-Dde-NPs (8) (Figure 2) . Then, the fluorophore was conjugated by amide bond formation following Dde deprotection (FAM-NPs (10)), and streptavidin was conjugated using glutaraldehyde as a cross-linker, following Fmoc deprotection, to achieve Strep-FAM-NPs (13). (1) FACS results were analysed using MFI (n = 3) in the APC channel, showing a strong MFI increase when the sandwich construct was complete ( Figure 4C) . Additionally, this validation has been performed using miR-122 sequence as a target (see Supporting Information 4 for more details). To validate the capacity of the Strep-FAM-NPs (13) to capture any biotinylated target, a second proof-of-concept assay was carried out. For this assay, a biotinylated KRAS nucleic acid sequence (ssDNA-KRAS-wt-biotin) and its complementary PNA labelled with the Cy5 fluorophore (PNA-KRAS-wt-Cy5) were used (see sequences in Table 1 ). After the formation of the PNA:DNA heteroduplex, the product was captured by Strep-FAM-NPs (13) (Figure 5A) . Flow cytometry analysis showed that the Strep-FAM-NPs (13) showing a strong MFI increase when the sandwich construct was complete ( Figure 5C ). The capacity of the system to detect the KRAS sequence as well as mutations present J o u r n a l P r e -p r o o f in a complex biological matrix and, by using FACS analysis, the system is capable to detect the presence of the KRAS G12C point mutation. The methodology developed in this work can be performed within three hours by using widely available reading platforms such as the flow cytometer with a limit of detection of 2.5 pmoles (12.5 nM). Although further optimisation has still to be done, for instance to increase the sensibility of this approach, this proof-of-concept could be adaptable and comparable to other existing methods currently used to detect point mutations [36] [37] [38] [39] . Herein, we have presented the development of bifunctional nanoparticles for capturing DCL products, in which hybridisation processes has been performed in solution-phase, enabling nucleic acid detection with single-base resolution using flow cytometry. This is the first time that DCL processes have been performed in solution (meaning that hybridisation processes are thermodynamically favourable) and DCL products have been read using bead-based platforms. To do so, novel bifunctional nanoparticles, Strep-FAM-NPs (13), containing streptavidin and fluorescein, were developed and characterised. These initial proof-of-concept experiments have demonstrated that these novel bifunctional nanoparticles are able to efficiently capture biotinylated and fluorescently labelled PNA:DNA heteroduplex. The system can detect DCL products in a complex biological matrix such as human plasma, and it is specific to discriminate single-base variations, in this case, discriminating a KRAS wild-type sequence and a KRAS G12C mutated sequence. The methodology developed in this work can be performed within three hours by using flow cytometry, widely used in molecular laboratories, with a limit of detection of 2.5 pmoles (12.5 nM). For these reasons, we consider this methodology can be adaptable and comparable to other existing methodologies used to detect point mutations. Furthermore, the wide possibility to conjugate cargoes of different natures such as different fluorophores as well as molecules to the PS-NPs, together with the DCL technology, will lead to the development of novel strategies for nucleic acid analysis with single-base resolution. Moreover, this study, which can be adapted to other chemistries used in molecular testing, as it enables the capture of biotinylated molecular products produced in solution, opens up opportunities to develop novel assay formats for nucleic acid genotyping and detection of high homologous sequencing directly from body fluids or amplicons obtained by endpoint PCR. Molecular Diagnostics: Past, Present, and Future KRAS mutation testing in metastatic colorectal cancer RNA Extraction Kits for COVID-19 Tests Are in Short Supply in US. The Scientist An alternative workflow for molecular detection of SARS-CoV-2 -escape from the NA extraction kit-shortage DNA analysis by dynamic chemistry Dynamic chemistry for enzymefree allele discrimination in genotyping by MALDI-TOF mass spectrometry Polymerase-free measurement of microRNA-122 with single base specificity using single molecule arrays: Detection of drug-induced liver injury A PCR-free technology to detect and quantify microRNAs directly from human plasma Diaz-Mochon, PCR-free and chemistry-based technology for miR-21 rapid detection directly from tumour cells New Platform for the Direct Profiling of microRNAs in Biofluids Díaz-Mochón, Direct Detection of miR-122 in Hepatotoxicity Using Dynamic Chemical Labeling Overcomes Stability and isomiR Challenges Amplificationfree profiling of microRNA-122 biomarker in DILI patient serums, using the luminex MAGPIX system José Díaz-Mochón, Identification of Trypanosomatids by detecting Single Nucleotide Fingerprints using DNA analysis by dynamic chemistry with MALDI-ToF Díaz-Mochón, A colorimetric strategy based on dynamic chemistry for direct detection of Trypanosomatid species DNA surface hybridization: Comparison of theory and experiment Physicochemical perspectives on DNA microarray and biosensor technologies Palladium-mediated intracellular chemistry Microsphere-based tracing and molecular delivery in embryonic stem cells Microsphere-mediated protein delivery into cells Microspherebased intracellular sensing of caspase-3/7 in apoptotic living cells Tracking cell proliferation using a nanotechnology-based approach Novel strategy for microsphere-mediated DNA transfection A versatile theranostic nanodevice based on an orthogonal bioconjugation strategy for efficient targeted treatment and monitoring of triple negative breast cancer A model for RAS mutation patterns in cancers: finding the sweet spot Ras oncogenes and their downstream targets Circulating microRNAs as potential markers of human drug-induced liver injury Synthesis of polystyrene microspheres and functionalization with pd0 nanoparticles to perform bioorthogonal organometallic chemistry in living cells A new network BLAST application for interactive or automated sequence analysis and annotation Color test for detection of free terminal amino groups in the solid-phase synthesis of peptides Number of nanoparticles per cell through a spectrophotometric method -A key parameter to assess nanoparticle-based cellular assays Measurement of protein using bicinchoninic acid Comparison of a PNA clamp PCR and an ARMS/Scorpion PCR assay for the detection of K-ras mutations Rapid clinical mutational testing of KRAS, BRAF and EGFR: A prospective comparative analysis of the Idylla technique with high-throughput next-generation sequencing A comparison of four methods for detecting KRAS mutations in formalinfixed specimens from metastatic colorectal cancer patients Schemes in Figures 1, 4 , 5, and 6 have been partially created using BioRender.com.